相关实验视频
Updated: Jun 25, 2025
10:58
Quantitation of Intra-peritoneal Ovarian Cancer Metastasis
Published on: July 18, 2016
10.9K
卵巢癌中的PROTACs:目前的进展和未来的前景
Makenzie Vorderbruggen1,2, Carlos A Velázquez-Martínez3, Amarnath Natarajan1,2
1Eppley Institute for Research in Cancer, University of Nebraska Medical Center, Omaha, NE 68198-6805, USA.
International journal of molecular sciences
|May 25, 2024
概括
使用向蛋白质分解的仿真体 (PROTACs) 的向蛋白质降解 (TPD) 为卵巢癌提供了一种新的治疗策略. 本综述探讨了卵巢癌模型中的PROTACs,并讨论了选择性输送和提高疗效的策略.
科学领域:
- 在瘤学瘤学.
- 分子生物学分子生物学
- 药物发现 药物发现 药物发现
背景情况:
- 卵巢癌是妇科癌症死亡率的主要原因之一.
- 晚期卵巢癌经常复发,目前的治疗方法往往缺乏治愈潜力.
- 对于卵巢癌治疗,迫切需要新的治疗策略.
研究的目的:
- 在卵巢癌模型中研究的蛋白质分解向嵌合体 (PROTACs) 的审查.
- 突出来自其他癌症的PROTAC,具有潜在的卵巢癌应用.
- 讨论选择性输送和用于卵巢癌的PROTACs药理学方面的进展.
主要方法:
- 在卵巢癌研究中对PROTACs的文献综述.
- 对在其他癌症类型中研究的PROTACs进行分析,以了解卵巢癌的潜在实用性.
- 探索针对性交付和改善药理动力学的策略.
主要成果:
- 目前在卵巢癌模型中测试的PROTACs的综述.
- 从其他恶性瘤中确定有前途的PROTAC候选者.
- 讨论在卵巢癌中使用PROTACs的启用技术.
结论:
- 在卵巢癌中,PROTACs是一种有前途的向蛋白质降解方法.
- 对选择性输送和优化药理动力学的进一步研究对于临床翻译至关重要.
- PROTACs有可能克服现有的卵巢癌治疗方法的局限性.
相关概念视频
02:57Targeted Cancer Therapies
7.6K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.6K
02:49Cancer Therapies
7.6K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
7.6K